Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 2014

View Archived Issues

Discovery Laboratories awarded SBIR grant for aerosolized KL4-surfactant

Phase III topline results for Intarcia's ITCA-650 for type 2 diabetes

Biofrontera reports preliminary results from phase III trial of Ameluz

Novel prophylactic human cytomegalovirus vaccine shows promise in vivo

Phase I trial of lirilumab in combination with elotuzumab begins

Eleven Biotherapeutics reports topline data from phase II study of EBI-005

Prophylix Pharma to begin phase I/II trials of NAITgam for prevention of FNAIT

Preclinical activity of a novel long-lasting antimycotic echinocandin

Clinical results presented for the novel cell-based anti-HIV therapy, SB-728-T

IL-10-modified autologous dendritic cells administered to patients with multiple sclerosis

BMS selects NeurOp NMDA receptor modulator for development for depression

Oxford BioTherapeutics and Berlin Chemie/Menarini select second anticancer antibody-drug conjugate

Novel analgesic compounds synthesized at Esteve

IBI-20089 and ranibizumab combination is well tolerated in phase I trial in AMD

Santen confirms closing of asset purchase agreement with Merck & Co.

PEGPH-20 receives orphan drug designation for pancreatic cancer

Novel IRAK-4 inhibitors disclosed by Biogen Idec

FDA grants orphan drug status to chariSMA for spinal muscular atrophy

Treatment begins in phase II study of RPC-4046 for eosinophilic esophagitis

AbbVie divulges novel PDE10A inhibitors

U.S. investigators synthesize novel anti-C. difficile antibodies

Bristol-Myers Squibb reports new KCNA5 channel blockers for arrhythmia

BioMarin Pharmaceutical presents novel HDAC inhibitors

Novartis prepares new IDH inhibitors for cancer

Actimmune receives U.S. orphan drug designation for Friedreich's ataxia

Boehringer Ingelheim presents phase III results for linagliptin/pioglitazone FDC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...